See All Slides -

Slides

Presentation TCT 2016

TCT 12: Real-world Utilization of Computed Tomography Derived Fractional Flow Reserve: Single Center Initial Experience in the United States

Presenter: Daniel S. Berman, Pamela S. Douglas, Anas Fares

October 31, 2016

Presentation TCT 2016

TCT 7: Relationship Between Traditional Risk Factors, Platelet Reactivity, and Thrombotic Events: A Mediation Analysis From ADAPT-DES

Presenter: Dimitrios Alexopoulos, Laurent Bonello, Bjorn Redfors

October 31, 2016

Presentation TCT 2016

TCT 4: The Impact of Residual Syntax Score in Octogenarian ACS Patients

Presenter: Andreas Baumbach, Kurt Huber, Seiichi Hiramori

October 31, 2016

Presentation TCT 2016

Rationale for and Design of COAPT: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Michael Argenziano, Alec S. Vahanian, Blase A. Carabello

October 31, 2016

Presentation TCT 2016

Dedicated Stents for Specific Scenarios: Historical Perspectives and Stuttering Progress

Presenter: Chaim S. Lotan, Giora Weisz, Martin B. Leon

October 31, 2016

Presentation TCT 2016

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Bo Xu

October 31, 2016

Presentation TCT 2016

A Multicenter, Prospective Registry of Transcaval access and closure for transcatheter aortic valve replacement

Presenter: Joseph A. Hill, Steven P. Marso, Adam B. Greenbaum

October 31, 2016

Presentation TCT 2016

TOPAS-TAVI: A Prospective, Multicenter Registry Evaluating Transcatheter Aortic Valve Implantation in Patients with Low-Flow, Low-Gradient Aortic Stenosis

Presenter: Spencer B. King III, Jagat Narula, Henrique B. Ribeiro

October 31, 2016

Presentation TCT 2016

Key Note Lecture I. FDA/CDRH State of the Union

Presenter: Matthew G. Hillebrenner, Gregg W. Stone, Jeffrey Shuren

October 31, 2016

Presentation TCT 2016

TCT 47: Secular Trends in Characteristics, Treatments, and Outcomes in Patients With Unprotected Left Main Coronary Artery Disease Over Two Decades

Presenter: Javier Escaned, Christoph K. Naber, Duk-Woo Park

October 31, 2016

Advertisement

Slides

TCT 12: Real-world Utilization of Computed Tomography Derived Fractional Flow Reserve: Single Center Initial Experience in the United States

TCT 7: Relationship Between Traditional Risk Factors, Platelet Reactivity, and Thrombotic Events: A Mediation Analysis From ADAPT-DES

TCT 4: The Impact of Residual Syntax Score in Octogenarian ACS Patients

Rationale for and Design of COAPT: What I Expect the Findings to Be But What Wont Surprise Me!

Dedicated Stents for Specific Scenarios: Historical Perspectives and Stuttering Progress

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

A Multicenter, Prospective Registry of Transcaval access and closure for transcatheter aortic valve replacement

TOPAS-TAVI: A Prospective, Multicenter Registry Evaluating Transcatheter Aortic Valve Implantation in Patients with Low-Flow, Low-Gradient Aortic Stenosis

Key Note Lecture I. FDA/CDRH State of the Union

TCT 47: Secular Trends in Characteristics, Treatments, and Outcomes in Patients With Unprotected Left Main Coronary Artery Disease Over Two Decades

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content